tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Srikripa Devarakonda, 137 are a BUY (92.57%), 11 are a HOLD (7.43%).
Analyst Srikripa Devarakonda, currently employed at TRUIST, carries an average stock price target met ratio of 64.57% that have a potential upside of 45.4% achieved within 210 days.
Srikripa Devarakonda’s has documented 293 price targets and ratings displayed on 26 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on SRRK, Scholar Rock Holding Corp at 24-Sep-2026.
Analyst best performing recommendations are on NMTR (9 METERS BIOPHARMA).
The best stock recommendation documented was for NMTR (9 METERS BIOPHARMA) at 6/30/2020. The price target of $400 was fulfilled within 1 day with a profit of $41 (11.42%) receiving and performance score of 114.21.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 21-Sep-2025
$157
$42.87 (37.56%)
$123
Hold Since 10-Feb-2026
$128
$13.87 (12.15%)
$101
Buy Since 04-Feb-2026
$152
$37.87 (33.18%)
$150
8 days ago
(27-Sep-2026)
0/18 (0%)
$27.18 (21.78%)
Hold Since 23-Oct-2022
$123
$8.87 (7.77%)
$110
8 days ago
(27-Sep-2026)
13/16 (81.25%)
$-1.82 (-1.46%)
87
Hold Since 02-May-2023
$109
$-5.13 (-4.49%)
$109
14 days ago
(21-Sep-2026)
49/57 (85.96%)
$-17.93 (-14.13%)
443
Which stock is Srikripa Devarakonda most bullish on?
Which stock is Srikripa Devarakonda most reserved on?
What Year was the first public recommendation made by Srikripa Devarakonda?
